Dimitrios Skaltsas ^UDM

Dimitrios Skaltsas, leading Intelligencia as Co-Founder & CEO, is at the forefront of integrating AI in drug development. The platform he oversees focuses on assessing and mitigating risks in clinical trials, thus bridging the gap between innovation and risk management in drug development. Intelligencia's interdisciplinary team, guided by Skaltsas, is committed to accelerating novel therapies for patients by offering insightful data analysis and predictive models.